Isibloom® (Desogestrel and Ethinyl Estradiol Tablets, USP) (generic ORTHO-CEPT®)

0.15 mg Desogestrel /0.03 mg Ethinyl Estradiol

$15/3 blister packs of 28 tablets each

FDA approved

$15.00

START NOW

Product Details

Isibloom® (desogestrel and ethinyl estradiol tablets, USP) provide an oral contraceptive regimen of 21 orange round tablets each containing 0.15 mg desogestrel and 0.03 mg ethinyl estradiol. To achieve maximum contraceptive effectiveness, Isibloom must be taken exactly as directed and at intervals not exceeding 24 hours. Isibloom may be initiated using either a Sunday start or a Day 1 start. For information on how to take Isibloom click here

What to Expect

In a clinical trial with desogestrel and ethinyl estradiol tablets, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. This represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. This rate includes patients who did not take the drug correctly. When they are taken correctly without missing any pills, the chance of becoming pregnant is approximately 1% (1 pregnancy per 100 women per year of use).

Select Safety Information

Stop Isibloom® if an arterial thrombotic event or venous thromboembolic (VTE) event occurs. Stop Isibloom® if there is unexplained loss of vision, proptosis, diplopia, papilledema, or retinal vascular lesions. Evaluate for retinal vein thrombosis immediately. Isibloom® is contraindicated in females over 35 years old who smoke. Advise the nursing mother to use other forms of contraception, when possible, until she has weaned her child. COCs can reduce milk production in breastfeeding mothers. This product (like all oral contraceptives) is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. Please click here for the complete boxed warning & for more Important Risk Information.
Please click here for full Prescribing Information and Patient Information.

Category: